Description
TIRZ – 10mg is a laboratory-grade Tirzepatide peptide designed specifically for research purposes. This compound acts as a dual agonist for glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, making it a significant focus in metabolic and endocrinology studies.
In ongoing research, Tirzepatide has demonstrated potential in modulating insulin secretion, improving glucose tolerance, and reducing appetite. It is being explored as a therapeutic candidate in the treatment of type 2 diabetes and obesity in experimental settings.
This 10mg formulation offers precise dosing for controlled lab experiments and is produced under strict quality standards to support reproducible results.
Research Use Only
This product is not approved for human or veterinary use. It is intended strictly for in vitro and laboratory research applications by qualified professionals.
